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ferent chemical compounds may produce
in the face of technological, social, and
economic restraints.
Some neurotoxicologists say the 1990s
could be named after the pancreas or the
lymph nodes, for all the benefit they've
seen from the "Decade of the Brain." The
decade's designation, made during the
Bush Administration, was the brainchild of
the White House's Office of
Science and Technology Policy
(OSTP) and was meant to draw
attention to all the major strides
the neurosciences had made in the
'80s and were expected to make in
the '90s. And in that it was success-
ful, at least in the beginning: the
public was fascinated by the ideas
that mental illness could arise from
an imbalance in brain neurotrans-
mitters and thatAlzheimer's disease
could result from an environmental
cause such as aluminum or zinc.
The Decade of the Brain was also
an ambitious attempt by an unoffi-
cial OSTP subcommittee on brain
and behavioral sciences to beef up
funding for basic brain sciences. The rip
Only a little of those monies have endeav
ever surfaced, and the original
OSTP steering group has since disbanded.
Butwhile the Decade ofthe Brain public
relations campaign may have failed to create
public awareness and produce funding, neu-
roscientists nationwide are quiedy celebrat-
ing on their own. They are hailing the
advances being made in the areas of neu-
roimmunology and neuroendocrinology that
may eventually lead to a greater understand-
ing ofhow physical (e.g., noise, light, radia-
tion, temperature), chemical (e.g., toxins,
drugs, solvents, pesticides), and psychologi-
cal (stress) environmental factors alter the
nervous system to produce adverse effects in
the body. Such advances will improve the
credibility ofthe field ofneurotoxicology.
Brain Science
Neuroscientists suddenly have the ability
to dissect toxic effects at the cellular and
molecular level to understand how toxins
target specialized neurons and nerve func-
tions. New investigations of neurotoxic
substances have produced headlines. EPA
investigators, working with university
researchers, have linked arsenic metals to
certain birth defects; scientists are now
looking more closely at the effects of lead
and mercury on the development of the
brain and cognitive function. In a reassess-
ment of the health risks of the weight-loss
drug dexfenfluramine, EPA scientists
found that it does not put patients at risk
of brain damage, contrary to earlier
research which found it caused levels ofthe
neurotransmitter serotonin to drop critical-
)pie effect. Scientists hope the Decade of the Brain will s
ors in the widening areas of brain research.
ly. It was observed that serotonin levels
bounced backwith no permanent damage.
In 1995, a workshop will be held to
highlight progress that has been made in
unraveling the roots ofParkinson's disease,
a degenerative disorder that robs its elderly
victims of muscle control. Parkinson's dis-
ease has all the promise of becoming a
highly visible neurotoxicology success story
because it offers the opportunity to deter-
mine if susceptibility to an environmental
toxin is at its root.
The relationship between the environ-
ment, diet, and the nervous system is also
being explored. Studies have suggested a
link between dietary consumption of trace
elements such as aluminum, copper, iron,
zinc, and lead and cognitive and psy-
chomotor dysfunction. In addition, dietary
factors including trace elements or malnu-
trition have been shown to greatly affect
the development of the fetal nervous sys-
tem, and studies are underway to evaluate
these interactions.
More research breakthroughs are
expected as the Decade of the Brain con-
tinues. However, all neuroscientists are
facedwith a monumental challenge: under-
standing the incredible complexity of the
brain and the effects that thousands ofdif-
Three-pound Universe
The brain's highly organized mass ofgray
and white matter acquires, stores, process-
es, and produces information, all aimed at
maintaining each human cell and each
body organ in optimal conditions. A
remarkable cellular specialization that
relies on excitability and impulse
Z conduction has evolved to
l accomplish these nervous system
functions. Many ofthe underly-
ing biochemical processes are
well known: generation and
maintenance of electrochemical
gradients, intracellular transport
systems, and synaptic neuro-
transmission.
But this exquisite specializa-
tion has come at a price. The
complex design ofthe brain and
the nervous system make it par-
ticularly vulnerable to environ-
mental insult. Development of
the brain, like other organs, is
dependent on a precise, elegantly
;pur new orchestrated set of processes,
which can be irrevocably disrupt-
ed. For example, once mature,
terminally differentiated neurons generally
can't replicate after damage, and axons of
the central nervous system have an
extremely limited capacity to regenerate.
Dependence ofnerve cells on aerobic respi-
ration and transport ofmolecules over long
distances make them easytargets.
The brain and nervous system suffer
from more than 1,000 disorders, and these
neurological illnesses affect more than 50
million Americans at costs exceeding $120
million annually. The causes of few of
these diseases can be explained, and no one
really knows how many of the mile-long
list of environmental toxins might have
deleterious effects, or how environmental
factors such as radiation, noise, and light
affect the interactions between the brain
and other bodilysystems.
An average person is exposed during
daily life to neuroactive, neurotoxic sub-
stances in air, water, foods, cosmetics,
household products, and drugs. Naturally
occurring neurotoxins, such as fish and
plant toxins, present other hazards. The
combination of unique molecular targets
and protective structures in the nervous
system is thought to underlie the selective
vulnerability of nervous tissue to certain
environmental toxins.
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increasing inventory of more than 65,000
chemicals, and an overwhelming majority
of the materials in commercial use have
not been tested for their neurotoxic poten-
tial. The EPA estimates that a large per-
centage of the more than 500 registered
active pesticide ingredients are neurotoxic
to some degree. According to a 1993 EPA
report, 167 of these chemicals affect the
nervous system or behavior. Some scien-
tists estimate that of the 200 chemicals to
which 1 million or more American workers
are exposed, more than one-third may have
adverse effects on the nervous system.
Neurotoxic effects are among the top 10
occupational disorders.
Black Box
It wasn't so long ago that regulators were
much less interested in the effects ofchem-
icals on the brain and central nervous sys-
tem than in gross damage such as effects
on organs or development of diseases like
cancer. "The brain was always seen as a
black box that had subtle connections and
networks," said Jean Harry, head ofa neu-
rotoxicology working group at the NIEHS.
"And no one knew why one pesticide
might damage this box, while another one
didn't. There are so many chemicals and so
much variation; changes in a single methyl
group would make a chemical easier to get
into the brain. Cancer elsewhere in the
body, on the other hand, was easy to use as
a marker oftoxicity."
"Cancer was an issue that everything
revolved around for 20 to 25 years, because
it is such a terrible disease, and you can tell
who has it and who doesn't," said Hugh
Tilson, head ofneurotoxicology research at
EPA's Health Effects Research Laboratory.
"Most federal regulations and program
models were therefore developed around
potential carcinogens."
At the same time cancerwas in the lime-
light, the fledgling field of neurotoxicology
attracted psychologists and others who
focused on the effects that chemicals such as
pesticides produce in behavior, both animal
and human. The tools they employed were
derived from experimental analysis of
behavior. While such research is valid, and
is still being conducted, it tells scientists lit-
tle about why those behaviors are altered.
"Up until recently, people assumed that the
only thing neurotoxicology could tell us was
about changes in behavior," said Harry.
"But now we know there is so much more
going on, such as learning, memory, the
function ofneurons."
"We all now realize there are other
important areas, such as reproduction,
development, and nervous system func-
tion, that are affected and that there are a
number of important toxic effects that are
not carcinogenic," said Tilson.
"We moved from the 'lump and bump'
kind ofovert effect into functional levels of
adverse health effects," said Thomas
Sobotka, research pharmacologist at the
Division of Toxicological Research within
FDA's Center for Food Safety and Applied
Nutrition. Instead of stressing animals
with lethal doses of toxins, "we can move
to cellular mechanisms, which are the real
root ofthe problem," Sobotka said.
The trend by neurotoxicologists to
embrace molecular biology began only
about five years ago. Most investigators
agree that the use of molecular biology
makes the field more valuable; and they say
that for the first time there is a real chance
for all areas of neurotoxicology to work
together. In the past, government regula-
tors and basic academic scientists have
tended to share neurotoxicology research
where feasible, but it has not been easy
because of their different goals. The end-
point of neurotoxicology in federal regula-
tory agencies has always been a marker that
can screen chemicals for health risks. On
the other hand, academic scientists use
neurotoxins as a tool to understand basic
processes. But now the twain shall meet.
Pieces ofthe Puzzle
Scientists at many major research institu-
tions are now focusing attention on new
evidence of the integration of human ner-
vous, immune, and endocrine systems.
Researchers such as David Felton, profes-
sor of neurobiology at the University of
Rochester, believe environmental insults to
the nervous or endocrine system may indi-
rectly affect immune function by stimulat-
ing the production of cytokines that acti-
vate the release of neurohormones and
neurotransmitters. Felton and colleagues
are developing integrated models to test
these interactions in connection with
autoimmune diseases such as lupus or
rheumatoid arthritis.
The effects ofenvironmental hormones
on pituitary function are the subject of
recent studies by Richard Peterson and col-
leagues at the University of Wisconsin.
The pituitary gland of the brain controls
endocrine function. Environmental hor-
mones such as dioxin may interfere with
the pituitary gland by causing hormonal
imbalances. Peterson exposed male rats to
2,3,4-tetrachloro-p-dioxin (TCDD) and
found that the chemical interfered with the
negative feedback system of the testes and
pituitary. Normally, when testosterone lev-
els are low, the pituitary secretes leutiniz-
ing hormone (LH), which tells the testes to
produce more testosterone. Although diox-
in lowers levels of plasma testosterone, it
actually increases the potency of testos-
terone and thus inhibits secretion of LH,
Brain cells. Development of glial cells (green),
shown growing on neurons, may be affected by
exposure to lead.
so the needed amount of testosterone is
not produced. This creates reproductive
deficits in the rats tested. TCDD has like-
wise been shown to affect testosterone lev-
els in humans by affecting the function of
the endocrine system.
Critical Collaborations
Not only are individual scientists using an
integrated approach to studying the ner-
vous system, but scientists from separate
disciplines are collaborating to develop
models for studying the brain. Such team-
work can be seen at Duke University
Medical Center, one ofthe few universities
that has established a toxicology training
and research center. Its proximity to the
NIEHS and the EPA in Research Triangle
Park, North Carolina, has helped to foster
collaboration. For example, Duke neurobi-
ologist Pate Skene is working with
NIEHS's Harry to understand how lead
perturbs early brain development, resulting
in learning deficits. Skene is studying the
processes by which genes regulate develop-
ment of neurons, and he believes that this
growth is orchestrated, with different types
of nerve cells signaling each other to grow
and function. Harry has found that glial
cells in the brain seem to be most affected
by lead, but she believes overall neuron
development is stymied. Harry and Skene
are now working together to see if glial
cells affected by lead signal other nerve cell
types to grow abnormally. Skene also plans
to test whether lead affects genes that
direct glial cell development. Thus, this
experiment can be used by both researchers
to answer different questions.
"This is a good two-way street," said
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Skene. "It costs me very litde to stay aware of
what the neurotoxicologists are doing and to
collaborate when highly targeted toxins are
useful in my research. Neurobiology is a
prime example in which toxins can reveal a
lotabout basicmechanisms."
Still, some nudges are needed to promote
collaboration, and one was recendy provided
by neuropathologist Doyle Graham, head of
the Integrated Toxicology Program at Duke
University, and Michael Sheetz, chair of
Duke's cell biology department. Graham was
interested in the toxicity ofacrylamide, used
in water treatment plants; Sheetz had the
highly advanced optical "laser tweezers" that
he used to watch how living nerve cells trans-
portmaterials.
Scientists know that exposure to acryl-
amide affects long nerve axons, resulting in
sensory loss and musde dysfunction in hands
and feet, and many have offered ideas as to
why this happens, although few have had the
chance to test those theories. Now Graham
and Sheetz are homing in on the ability of
acrylamide to interferewith the movement of
microtubule motors down an
axon.
"Sheetz had not used neuro-
toxic compounds to help under-
stand axonal transport. And I was
primarily interested in how these
toxins work. Together, we are
working on both our agendas,"
said Graham.
At the National Institutes of
Health, the principles of neuro-
toxicology "are spread around the
institutes" and are used diversely
in a wide variety ofbasic science Hugh Tilsoi
programs, said John Glowa, a number of
neurotoxicologist who works at effects that
the National Institute ofDiabetes genic.
and Digestive and Kidney Diseases. "It ranges
from peoplewho use it because theyare inter-
ested in transcription factors to psychiatrists
studying mental health to clinicians who look
at disease effects," he said.
Glowa, for example, studies the effects of
neurological damage caused by people who
abuse toxic solvents in glue and butane in
lighter fluid. He looks at the effects of these
and other substances, like cocaine, on neuro-
transmitters. Regulatory agencies such as the
EPA and the FDA have a more specific agen-
da. They are interested in using neurotoxicol-
ogy to help develop markers for nerve dam-
age to screen chemicals for neurotoxic effects.
"We want to make the transition between
basic principles and how we can apply risk
assessments," said William Slikker, director of
the division of neurotoxicology at FDA's
National Center for Toxicological Research
(NCTR). "We look at neurotoxicology as
giving us the ability to assess a wide range of
endpoints to make a total profile, such as
neurophysiology, neuropathology, neuro-
0-
imp
are
chemistry, and behavior. This is
unlike cancer research, where a
tumor is the endpoint ofinterest
in both rats and animals." The
center's three-year-old neurotox-
icology group has already count-
ed some successes, including a
detailed understanding ofhow
domoic acid blunts human
memory; this information is
used to help regulate the shell-
fish industry.
At the EPAseveral years ago, Jean Harry-
excitement was generated by a ogy can tell
new assay that helps detect neu- what goes a
rological damage in animals. than justbeh
The assay measures levels of a
brain protein known as glial fibrillary acidic
protein (GFAP), which increase after injury
to the brain. EPA regulators now hope that
similar biomarkers, including genetic mark-
ers, can be developed that reveal specific types
ofneurotoxic exposures in vitro. "We want to
move beyond 'check-a-box' animal toxicolo-
gy," or rote and excessive use of animals to
test toxiceffects, saidTilson.
co
Finding Funding
Chances to advance a field
dramatically come rarely.
The Decade of the Brain
project is a case in point.
Like most other government
initiatives, the Decade ofthe
Brain was seen by the players
realistically-as a short-term
funding mechanism. Each of
the group's members, which
-There are a included all the major feder-
portant toxic al agencies and NIH branch-
not carcino- es went back to their organi-
zations to lobby for new
funding before "the enhanced awareness of
this initiative dies out in favor of the next
new thing," said Tilson.
Lobbying for funding has been an ago-
nizing process. Aided by support from the
American Psychological Association,
Congress mandated in 1992 that the EPA
set aside $3 million over three years for
new research in neurotoxins.
The money was not new
funds; it would be covered
under EPA's total appropria-
tion. At the same time, Tilson
won approval from the EPA
to distribute those funds to
three areas: susceptible popu-
lations, environmental deter-
minants of neurodegenerative -
diseases, and in vitro methods _
of testing. After some delays,
$1 million was awarded in Doyle Graha 1993 funding, and Tilson s in neurotoxin
group sponsored competitive integrated in
cooperative research agree- tific disciplin
-N
us
oni
iavic
am-
lcol
nto
ies.
ments with university labora-
z tories to help the EPA design
tests to identify neurotoxic
effects in living cells. The
next year, funds looked
uncertain, but another $1
million came, and Tilson's
group awarded competitive
agreements to examine the
role of pesticide exposure in
Parkinson's disease and to
investigate at what levels
occupational exposure to leurotoxicol-
more about manganese causes neurotox-
in the brain icity. Expecting another
or. stop-start funding process,
Tilson makes no estimates as
to when he will receive the final $1 mil-
lion. Others point to the chronic lack of
research funding for neurotoxicology stud-
ies that was not addressed in this or previ-
ous decades; in fact, said Graham, almost
all the toxicity research being funded by
the NIH, apart from that at NIEHS, is for
toxins as tools to understand basic neuro-
biology. Other federal agency money is for
risk assessment techniques, not basic or
applied neurotoxicology research.
But while the Decade ofthe Brain may
not have produced much funding, it has
fostered a certain recognition ofneurotoxi-
cology among scientists, said NIEHS's
Harry. "For me, there has been better
acceptance of neurotoxicology here. For a
long time, other toxic effects, such as organ
deficits and cancer, were thought to be
much more important than nervous system
damage, but that's not so true anymore."
And others say that such recognition,
in combination with scientific progress,
has led to new efforts to keep the momen-
tum going. Sobotka said that the Decade
of the Brain underscored the "wheels of
change" that were in full swing in the
1980s and that have led to the ability of
FDA to update its "Redbook" rules of reg-
ulation. The proposed changes to these
rules, the first since 1982, will allow the
FDA to more closly scrutinize the neuro-
toxic effects of hundreds of food additives
and artificial colors.
Slikker said that at
, NCTR, a new, 30-member
-, interagency group of re-
searchers has snatched the
baton offered by the Decade
of the Brain and is running
with it. They have kept the
scientific community focused
on neurotoxicology by pub-
lishing in the FederalRegistera
1993 "Draft Report: Princi-
-Advances ples of Neurotoxicology Risk
-og must be Assessment." To keep the
other scien- field moving forward, an
updated version ofthese prin-
Environmental Health Perspectives 922ciples was published in the August 17 issue
of the register. "We have taken this on as a
way to fulfill the goals of the original
Decade of the Brain committee" which
disbanded under the Clinton Admin-
istration, said Slikker.
Although by all accounts neurotoxicol-
ogy is just now coming into its own, some
scientists caution that it might be time to
regroup. Some worry that the field's
plunge into molecular biology may leave
neurotoxicologists without the "big pic-
ture" approach that will ultimately make
an impact on public health.
The science community is already frag-
mented, according to Peter Spencer, direc-
tor of the Center for Research on Occupa-
tional and Environmental Toxicology at
Oregon Health Sciences University. "We
are a collection of miniature groups that
focus on chemicals, and one group or
agency often doesn't know what the other
is doing. We have a narrow point ofview of
neurotoxicology," he said.
Rather, neurotoxicologists should take
more of a holistic view of environmental
contaminants, both natural and synthetic,
by engaging in both basic and applied
research on the adverse affects of occupa-
tional and environmental agents, said
Spencer, who is well known for the discov-
ery of neurotoxic effects of the cycad plant
in Guam. The goal must be disease preven-
tion, he added. Academic scientists must be
interested in the social problems ofthe envi-
ronment, as well as in basic mechanisms.
And regulatory agencies must expand their
view to more than "toxic endpoints," said
Spencer. "I want to help build a science of
neurotoxicology. I don't just want to look at
the chemical ofthe month."
Graham agrees that the advances made
by neurotoxicologists must be integrated
into a common science understood by clini-
cians. He sees that doctors treating people
afflicted by toxic diseases are not trained in
toxicology, and the opposite is also true-
few neurotoxicologists see the medical side.
'True progress requires people to see a
problem in a lot ofways: anatomically, over
time, through basic biology, by cellular
mechanisms," said Graham. "But it's hard
for scientists to pay all those entryfees."
Nevertheless, unraveling the mysteries
of the body's most complicated organ will
demand a coordinated strategy. Re-
searchers from all areas of neuroscience-
neurotoxicology, neurobiology, neuroim-
munology, and neuroendocrinology-will
have to work together to make the Decade
ofthe Brain a true decade ofdiscovery.
ReneeTwombly
Excitotoxicology
Neurotoxicologists ofall stripes are, well, excited about excitotoxins. These substances
are popping up with regular frequency as a definable dass ofenvironmental neurotox-
icants, villains that may be responsible for outbreaks ofmysterious diseases or even
some chronic illnesses. They have been implicated in disorders that range from poi-
soningfrom eating contaminated shellfish in the NorthAlantic or the grass peaplant
in Asia and Africa to the roots ofHuntington's and other neurodegenerative diseases.
Excitotoxins flood brain synapses to the point that they excite nerves to death. Using
molecular tools, neurotoxicologists are looking at changes in the brain that can turn
endogenous excitatory amino acids, such as glutamate, into cellular killers.
The outbreak ofdisease caused by domoic acid was an event that helped put exci-
totoxins, and its neuroxixicology sleuths, in the public eye. Domoic acid, a natural
excitotoxin, was found in diatoms consumed by blue mussels, which were, in turn,
eaten by Nova Scotians in 1987. The acid produced a strange, sometimes chronic loss
ofshort-term memory, which was later traced to the ability ofdomoic acid to trigger
excitatory receptors in the brain. Research by the National Center for Toxicological
Research has found that the acid's primary target is the hippocampus, which is
involved in memory retention. Further work established relative doses that produce
lesions in the hippocampus, and led in 1992 to an expanded FDA shellfish monitor-
ing program that detected unacceptable levels of the substance in dams and crabs
taken from the Pacific Northwest.
Now the FDA and neurotoxicologists elsewhere are contributing to both the pub-
lic's health and to basic science byworking on ways to detect domoic acid in seawater
while continuing to research the mechanisms of domoic acid excitotoxins, and ulti-
mat uncover the basic science of the glutamate system and receptor sensitivity.
Au;o%El\lES_E##0g # CiF iE 0< 0 2 Some investigators have
N ~~~~~~proposed that chronic
neurodegeneration, as
seen in amyotrophic later-
al sderosis, Huntington's
disease, and Parkinson's
disease, may also result
from increased sensitivity
to endogenous glutamate
toxicity.
XfThe scientific basis for
these proposals comes
from a number ofinvesti-
gations, including the
study of cycad plant poi-
soning in Guam, but the
Shell-shocked. Scientists are studying excitotoxins in shellfish
for clues asto howthey excite brain cellsto death. comes from the study of MPTP, an impurity
found in "synthetic hero-
in." Drug users developed
a Parkinsonian disorder when the contaminated heroin was injected. A number of
researchers found that MPTP produced excitotoxin lesions. Further work has led to
the theory that defective mitochondrial respiration may increase the sensitivity of
neurons to endogenous glutamate, culminating in chronic nerve death like the kind
seen in a number ofneurodegenerative diseases.
Metals in the environment and excitotoxins may also act in concert. The theory
that aluminum, a known neurotoxin, helps promote Alzheimer's disease is still being
explored. Neurotoxicologists atWashington University are studyingwhether zinc and
the cycad plant's excitotoxin work together. Scientists at the University ofRochester
areworking to measure how lead affects glutamate and neurotransmitter function.
The next level ofresearch will involve how genes may make some people suscepti-
ble to toxic, and excitotoxic, damage, said Doyle Graham, a neuropathologist who
leads the Integrated Toxicology Program at Duke University Medical Center. It may
be that a missing or defective gene leads to disease caused by environmental toxins.
Conversely, discoveries in the mechanisms oftoxic damage may lead to the search for
relevant genes. As Graham puts it, "All of the environmental camp is watching the
geneticists and vice versa."
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